Advestra advises on the IPO of SKAN

SKAN Group AG, a glob­al mar­ket lead­er in high-qual­ity isol­at­or sys­tems for aseptic pro­duc­tion pro­cesses in the (bio)pharmaceutical industry, suc­cess­fully lis­ted its shares on the SIX Swiss Exchange. Con­cur­rently with the IPO, SKAN Group AG (formerly BV Hold­ing AG) com­pleted a quasi-mer­ger and its shares were del­is­ted from BX Swiss. The total volume of the offer­ing was approx­im­ately CHF 243 mil­lion in the base offer­ing and CHF 270 mil­lion if the over-allot­ment option is exer­cised in full.

Cred­it Suisse and Ber­en­berg acted as Joint Glob­al Coordin­at­ors in this transaction.

Advestra acted as leg­al coun­sel to Cred­it Suisse and Ber­en­berg. The team included Alex­an­der von Jein­sen, Annina Ham­mer, Anna Capaul, Valérie Bayard as well as Thomas Reut­ter (all Cap­it­al Mar­kets and Cor­por­ate | M&A) and Markus Müh­le­mann (Tax).